Sanofi www.sanofi.com announced results from a phase 3 trial assessing Dupixent (dupilumab) in patients 12 years and older with eosinophilic esophagitis (EoE). The trial met its…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.